Captor Therapeutics SA - ESG Rating & Company Profile powered by AI
The assessment of Captor Therapeutics SA leverages data points from across the web as well as from public filings by Captor Therapeutics SA. This ESG assessment for Captor Therapeutics SA indicates the company's transparency towards the United Nations SDGs. This webpage of Captor Therapeutics SA was prepared by All Street Sevva using leading NLP.
Captor Therapeutics SA in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 5.3, social score of 4.8 and governance score of 8.0.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| 43 | Cyprotex Ltd | 6.2 | High |
| 43 | Rhythm Biosciences Ltd | 6.2 | High |
| 45 | Captor Therapeutics SA | 6.0 | High |
| 46 | Incanthera PLC | 5.8 | High |
| 46 | Fluicell AB | 5.8 | High |
| ... | ... | ... | |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Captor Therapeutics SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Captor Therapeutics SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Captor Therapeutics SA report the average age of the workforce?
Sign up for free to unlockDoes Captor Therapeutics SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Captor Therapeutics SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Captor Therapeutics SA disclose cybersecurity risks?
Sign up for free to unlockDoes Captor Therapeutics SA offer flexible work?
Sign up for free to unlockDoes Captor Therapeutics SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Captor Therapeutics SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Captor Therapeutics SA conduct supply chain audits?
Sign up for free to unlockDoes Captor Therapeutics SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Captor Therapeutics SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Captor Therapeutics SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Captor Therapeutics SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Captor Therapeutics SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Captor Therapeutics SA disclose water use targets?
Sign up for free to unlockDoes Captor Therapeutics SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Captor Therapeutics SA have a product recall in the last two years?
Sign up for free to unlockDoes Captor Therapeutics SA disclose incidents of discrimination?
Sign up for free to unlockDoes Captor Therapeutics SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Captor Therapeutics SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Captor Therapeutics SA disclose parental leave metrics?
Sign up for free to unlockDoes Captor Therapeutics SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Captor Therapeutics SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Captor Therapeutics SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Captor Therapeutics SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Captor Therapeutics SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Captor Therapeutics SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Captor Therapeutics SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Captor Therapeutics SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Captor Therapeutics SA disclose its waste policy?
Sign up for free to unlockDoes Captor Therapeutics SA report according to TCFD requirements?
Sign up for free to unlockDoes Captor Therapeutics SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Captor Therapeutics SA disclose energy use targets?
Sign up for free to unlockDoes Captor Therapeutics SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Captor Therapeutics SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Captor Therapeutics SA
These potential risks are based on the size, segment and geographies of the company.
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage. The company was incorporated in 2015 and is based in Wroclaw, Poland.